Millennium Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-22,419
| Closed | -$13K | – | 7075 |
|
|
2023
Q1 | $13K | Buy |
+22,419
| New | +$17.8K | ﹤0.01% | 5977 |
|
|
2022
Q1 | – | Sell |
-4,708
| Closed | -$32K | – | 7829 |
|
|
2021
Q4 | $32K | Buy |
4,708
+1,486
| +46% | +$15.2K | ﹤0.01% | 6560 |
|
|
2021
Q3 | $38K | Buy |
3,222
+666
| +26% | +$9.21K | ﹤0.01% | 6615 |
|
|
2021
Q2 | $48K | Buy |
+2,556
| New | +$47.6K | ﹤0.01% | 6374 |
|
|
2020
Q1 | – | Sell |
-2,163
| Closed | -$64K | – | 4704 |
|
|
2019
Q4 | $64K | Buy |
+2,163
| New | +$51.8K | ﹤0.01% | 4073 |
|
|
2017
Q2 | – | Sell |
-112
| Closed | -$69K | – | 3992 |
|
|
2017
Q1 | $69K | Buy |
+112
| New | +$39.8K | ﹤0.01% | 3362 |
|
|
2016
Q1 | – | Sell |
-390
| Closed | -$193K | – | 3771 |
|
|
2015
Q4 | $193K | Buy |
+390
| New | +$282K | ﹤0.01% | 3102 |
|
|
2015
Q3 | – | Sell |
-87
| Closed | -$153K | – | 3823 |
|
|
2015
Q2 | $153K | Buy |
+87
| New | +$135K | ﹤0.01% | 3096 |
|
|
2015
Q1 | – | Sell |
-94
| Closed | -$94K | – | 4240 |
|
|
2014
Q4 | $94K | Buy |
+94
| New | +$94.2K | ﹤0.01% | 3778 |
|
Other funds holding VYNT
Millennium Management's VYNT Position: Q2 2023 in Review
Millennium Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2023, closing a stake of 22,419 shares — an estimated $13K sold.
Millennium Management first reported a position in VYNT in Q4 2014 and held it in 9 quarters. The position peaked at $193K in Q4 2015. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.
- Millennium Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Millennium Management sold 22,419 Vyant Bio, Inc. Common Stock shares in Q2 2023, an estimated $13K.
- Millennium Management first reported a position in Vyant Bio, Inc. Common Stock in Q4 2014 and held it in 9 quarters.
- Millennium Management's Vyant Bio, Inc. Common Stock position peaked at $193K in Q4 2015.
- 1 fund tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2023.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.